IPCA Laboratories Limited

DecreasedQuarterly

IPCALABPharmaceuticalsMarket Cap₹51K Cr

Stake

1.56% → 1.39%

HDFC Life Insurance

Institution

The move

HDFC Life Insurance decreased its stake in IPCA Laboratories Limited from 1.56% to 1.39%, selling 429,112 shares. The value of the shares sold is ₹82.3 Cr at a price of ₹1920.40 apiece.

About IPCA Laboratories Limited

Visit stock

A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.

About HDFC Life Insurance

Visit investor

HDFC Life Insurance Company Limited, institutional investor in Indian equities

Get the next move the moment it happens.

Follow HDFC Life Insurance and IPCA Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

IPCA Laboratories Limited shareholders HDFC Life Insurance's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in IPCA Laboratories Limited

Axis Mutual FundIncreased

Axis Mutual Fund increased its stake in IPCA Laboratories from 1.83% to 1.94%, buying 2,78,227 shares at ₹1920.40 apiece, for a total value of ₹53.43 Cr.

19 Jul 2026

Edelweiss Mutual FundIncreased

Edelweiss Mutual Fund increased its stake in IPCA Laboratories Limited from 1.03% to 1.19%, raising its shareholding from 2,602,635 to 3,019,905 shares. This represents an increase of 417,270 shares.